Regardless of a viral, autoimmune, or chemotherapy-induced trigger, many inflammatory cardiac diseases converge on NLRP3 activation and the release of pro-inflammatory cytokines such as IL-1β and IL-18. Here, IL18 is linked to heart disorder.